Intellectual Property

PathMaker Neurosystems has exclusive worldwide rights to a fundamental portfolio of IP covering multi-site neuromodulation, consisting of over 70 issued patents to date and numerous cases moving forward.  We pioneered the field of multi-site meuromodulation, and our foundational IP reflects this innovation.  Our DoubleStim® technology which underlies our MyoRegulator® that is currently being used in ALS clinical trials is covered by over 40 issued patents in US, Europe and other territories. PathMaker holds trademark rights in its own corporate trademarks.